Rybelsus 3 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FP6C9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,317
Award facts
- Contract value 100% obligated
- $12,316.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,316.62 to AmerisourceBergen Drug Corp for the supply of Rybelsus 3 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. Rybelsus, a diabetes medication, aligns with AmerisourceBergen's established portfolio of endocrinology treatments supporting federal healthcare programs. As a child contract under the larger indefinite delivery vehicle, this delivery order exemplifies the company's role in the Defense Logistics Agency's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DB25FP6C9?
SPE2DB25FP6C9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FP6C9 worth?
The government has obligated $12,317 on SPE2DB25FP6C9.
Is contract SPE2DB25FP6C9 an order under another contract?
Yes. SPE2DB25FP6C9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP6C9 competed?
The extent of competition for SPE2DB25FP6C9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award